For example, hampering the function of immune-responsive gene 1 (Irg1), which encodes an enzyme synthesizing itaconate from the TCA cycle intermediate cis-aconitate, in tumor-resident macrophages, leads to reduced itaconate production and decreases tumor progression [33]. This evidence concerns the gene ACOD1 and neoplasm.